[Migraine prevention with dihydroergotamine].
D000328:Adult; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004087:Dihydroergotamine / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D011897:Random Allocation
D003692:Delayed-Action Preparations; D004087:Dihydroergotamine
Migräneprophylaxe mit Dihydroergotamin.